Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

The Right Time to Safely Re-Evaluate Empirical Antimicrobial Treatment of Hip or Knee Prosthetic Joint Infections.

Deroche L, Bémer P, Valentin AS, Jolivet-Gougeon A, Tandé D, Héry-Arnaud G, Lemarié C, Kempf M, Bret L, Burucoa C, Corvec S, Plouzeau C.

J Clin Med. 2019 Dec 2;8(12). pii: E2113. doi: 10.3390/jcm8122113.

2.

First Detection in Helicobacter suis of a Mutation Conferring Resistance to Clarithromycin in Helicobacter pylori: Case Report and Review of the Literature.

Pichon M, Broutin L, Touroult-Jupin P, Cremniter J, Plouzeau C, Faure JP, Olivier R, Burucoa C.

Microb Drug Resist. 2019 Nov 21. doi: 10.1089/mdr.2019.0270. [Epub ahead of print]

PMID:
31750765
3.

Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection.

Delchier JC, Bastuji-Garin S, Raymond J, Megraud F, Amiot A, Cambau E, Burucoa C; HELICOSTIC Study Group.

Med Mal Infect. 2019 Jun 27. pii: S0399-077X(18)30185-9. doi: 10.1016/j.medmal.2019.06.001. [Epub ahead of print]

PMID:
31257067
4.

Probabilistic chemotherapy in knee and hip replacement infection: the place of linezolid.

Deroche L, Plouzeau C, Bémer P, Tandé D, Valentin AS, Jolivet-Gougeon A, Lemarié C, Bret L, Kempf M, Héry-Arnaud G, Corvec S, Burucoa C, Arvieux C, Bernard L; and the CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study Group.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1659-1663. doi: 10.1007/s10096-019-03594-z. Epub 2019 Jun 15.

PMID:
31203474
5.

Prevalence of Helicobacter pylori and Its Associated Factors among Healthy Asymptomatic Residents in the United Arab Emirates.

Khoder G, Muhammad JS, Mahmoud I, Soliman SSM, Burucoa C.

Pathogens. 2019 Apr 1;8(2). pii: E44. doi: 10.3390/pathogens8020044.

6.

Impact of the Gastro-Intestinal Bacterial Microbiome on Helicobacter-Associated Diseases.

Pichon M, Burucoa C.

Healthcare (Basel). 2019 Feb 22;7(1). pii: E34. doi: 10.3390/healthcare7010034. Review.

7.

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag® H. pylori + ClariR assay.

Hays C, Delerue T, Lamarque D, Burucoa C, Collobert G, Billöet A, Kalach N, Raymond J.

Helicobacter. 2019 Apr;24(2):e12560. doi: 10.1111/hel.12560. Epub 2018 Dec 12.

PMID:
30548730
8.

Class 1 integrons in Acinetobacter baumannii: a weak expression of gene cassettes to counterbalance the lack of LexA-driven integrase repression.

Couvé-Deacon E, Jové T, Afouda P, Barraud O, Tilloy V, Scaon E, Hervé B, Burucoa C, Kempf M, Marcos JY, Ploy MC, Garnier F.

Int J Antimicrob Agents. 2019 Apr;53(4):491-499. doi: 10.1016/j.ijantimicag.2018.11.012. Epub 2018 Nov 23.

9.

Low-level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study.

Sia R, Plouzeau C, Godonou HSM, Guingané A, Coulibaly A, Somda S, Sermé AK, Burucoa C.

Helicobacter. 2019 Feb;24(1):e12551. doi: 10.1111/hel.12551. Epub 2018 Nov 12. No abstract available.

PMID:
30417953
10.

Treatment compliance with European guidelines and prognosis of Clostridium difficile infection according to age.

Lauda-Maillen M, Liuu E, Catroux M, Caupenne A, Priner M, Cazenave-Roblot F, Burucoa C, Ingrand P, Paccalin M.

Med Mal Infect. 2019 May;49(3):173-179. doi: 10.1016/j.medmal.2018.08.001. Epub 2018 Sep 25.

PMID:
30266433
11.

A fatal case of Streptococcus uberis endocarditis on cardiovascular implantable electronic device.

Meriglier E, Michaud A, Plouzeau C, Raud-Raynier P, Burucoa C, Roblot F.

Med Mal Infect. 2018 Dec;48(8):549-551. doi: 10.1016/j.medmal.2018.07.003. Epub 2018 Sep 3. No abstract available.

PMID:
30190163
12.

Pseudomonas aeruginosa flagellum is critical for invasion, cutaneous persistence and induction of inflammatory response of skin epidermis.

Garcia M, Morello E, Garnier J, Barrault C, Garnier M, Burucoa C, Lecron JC, Si-Tahar M, Bernard FX, Bodet C.

Virulence. 2018;9(1):1163-1175. doi: 10.1080/21505594.2018.1480830.

13.

Performances of the IDEIA HpStAR Stool Antigen Test in Detection of Helicobacter pylori Infection Before and After Eradication Treatment in Algerian Children.

Moubri M, Burucoa C, Kalach N, Larras RR, Nouar N, Mouffok F, Arrada Z.

J Trop Pediatr. 2019 Jun 1;65(3):210-216. doi: 10.1093/tropej/fmy035.

PMID:
30007342
14.

Histopathological Diagnosis of Prosthetic Joint Infection: Does a Threshold of 23 Neutrophils Do Better than Classification of the Periprosthetic Membrane in a Prospective Multicenter Study?

Bémer P, Léger J, Milin S, Plouzeau C, Valentin AS, Stock N, Jolivet-Gougeon A, Moreau A, Corvec S, Quintin-Roue I, Tandé D, Héry-Arnaud G, Rousselet MC, Lemarié C, Kempf M, Michenet P, Bret L, de Pinieux G, Burucoa C; CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study Team.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00536-18. doi: 10.1128/JCM.00536-18. Print 2018 Sep.

15.

Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes.

Cremniter J, Bodet C, Tougeron D, Dray X, Guilhot J, Jégou JF, Morel F, Lecron JC, Silvain C, Burucoa C.

Helicobacter. 2018 Jun;23(3):e12479. doi: 10.1111/hel.12479. Epub 2018 Mar 27.

PMID:
29582503
16.

Molecular characterization of Helicobacter pylori resistance to rifamycins.

Hays C, Burucoa C, Lehours P, Tran CT, Leleu A, Raymond J.

Helicobacter. 2018 Feb;23(1). doi: 10.1111/hel.12451. Epub 2017 Nov 23.

PMID:
29168600
17.

Erythromycin encapsulation in nanoemulsion-based delivery systems for treatment of Helicobacter pylori infection: Protection and synergy.

Tran LTC, Gueutin C, Frebourg G, Burucoa C, Faivre V.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):146-151. doi: 10.1016/j.bbrc.2017.09.060. Epub 2017 Sep 14.

PMID:
28917836
18.

Epidemiology of Helicobacter pylori infection.

Burucoa C, Axon A.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12403. Review.

PMID:
28891138
19.

Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study.

Malandain D, Bémer P, Leroy AG, Léger J, Plouzeau C, Valentin AS, Jolivet-Gougeon A, Tandé D, Héry-Arnaud G, Lemarié C, Kempf M, Bret L, Burucoa C, Corvec S; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

Clin Microbiol Infect. 2018 Jan;24(1):83.e1-83.e6. doi: 10.1016/j.cmi.2017.05.017. Epub 2017 May 27.

20.

Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter Study.

Bouihat N, Burucoa C, Benkirane A, Seddik H, Sentissi S, Al Bouzidi A, Elouennas M, Benouda A.

Microb Drug Resist. 2017 Sep;23(6):727-732. doi: 10.1089/mdr.2016.0264. Epub 2016 Dec 20.

PMID:
27996373
21.

Inflammatory signaling pathways induced by Helicobacter pylori in primary human gastric epithelial cells.

Tran CT, Garcia M, Garnier M, Burucoa C, Bodet C.

Innate Immun. 2017 Feb;23(2):165-174. doi: 10.1177/1753425916681077. Epub 2016 Dec 5.

PMID:
27913793
22.

First case report of a human sepsis involving a recently identified anaerobic agent: Bacteroides faecis.

Garcia M, Bouvet P, Petitpas F, Jayle C, Legeay C, Sautereau J, Michaud A, Burucoa C, Plouzeau C.

Anaerobe. 2016 Dec;42:74-77. doi: 10.1016/j.anaerobe.2016.08.004. Epub 2016 Aug 18.

PMID:
27544037
23.

In vitro culture and phenotypic and molecular characterization of gastric stem cells from human stomach.

Garcia M, Chomel JC, Mustapha P, Tran CT, Garnier M, Paris I, Quellard N, Godet J, Cremniter J, Bennaceur-Griscelli A, Lecron JC, Turhan AG, Burucoa C, Bodet C.

Helicobacter. 2017 Apr;22(2). doi: 10.1111/hel.12351. Epub 2016 Sep 4.

PMID:
27592706
24.

How Many Samples and How Many Culture Media To Diagnose a Prosthetic Joint Infection: a Clinical and Microbiological Prospective Multicenter Study.

Bémer P, Léger J, Tandé D, Plouzeau C, Valentin AS, Jolivet-Gougeon A, Lemarié C, Kempf M, Héry-Arnaud G, Bret L, Juvin ME, Giraudeau B, Corvec S, Burucoa C; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

J Clin Microbiol. 2016 Feb;54(2):385-91. doi: 10.1128/JCM.02497-15. Epub 2015 Dec 4.

25.

High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study.

Djennane-Hadibi F, Bachtarzi M, Layaida K, Ali Arous N, Nakmouche M, Saadi B, Tazir M, Ramdani-Bouguessa N, Burucoa C.

Microb Drug Resist. 2016 Apr;22(3):223-6. doi: 10.1089/mdr.2015.0209. Epub 2015 Nov 10.

PMID:
26554340
26.

Multiple and mixed Helicobacter pylori infections: Comparison of two epidemiological situations in Tunisia and France.

Ben Mansour K, Fendri C, Battikh H, Garnier M, Zribi M, Jlizi A, Burucoa C.

Infect Genet Evol. 2016 Jan;37:43-8. doi: 10.1016/j.meegid.2015.10.028. Epub 2015 Oct 28.

PMID:
26518911
27.

Nosocomial outbreak of Pseudomonas aeruginosa associated with a drinking water fountain.

Costa D, Bousseau A, Thevenot S, Dufour X, Laland C, Burucoa C, Castel O.

J Hosp Infect. 2015 Nov;91(3):271-4. doi: 10.1016/j.jhin.2015.07.010. Epub 2015 Aug 17.

PMID:
26341271
28.

Antibacterial activities of oxyprenylated chalcones and napthtoquinone against Helicobacter pylori.

Bodet C, Burucoa C, Rouillon S, Bellin N, Taddeo VA, Fiorito S, Genovese S, Epifano F.

Nat Prod Commun. 2014 Sep;9(9):1299-301.

PMID:
25918797
29.

High-level primary clarithromycin resistance of Helicobacter pylori in Morocco: a prospective multicenter molecular study.

Bouilhat N, Burucoa C, Benkirane A, El Idrissi-Lamghari A, Al Bouzidi A, El Feydi A, Elouennas M, Benouda A.

Helicobacter. 2015 Dec;20(6):422-3. doi: 10.1111/hel.12219. Epub 2015 Mar 3. No abstract available.

PMID:
25735573
30.

First experience of a multicenter external quality assessment of molecular 16S rRNA gene detection in bone and joint infections.

Plouzeau C, Bémer P, Valentin AS, Héry-Arnaud G, Tandé D, Jolivet-Gougeon A, Vincent P, Kempf M, Lemarié C, Guinard J, Bret L, Cognée AS, Gibaud S, Burucoa C, Corvec S; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

J Clin Microbiol. 2015 Feb;53(2):419-24. doi: 10.1128/JCM.02413-14. Epub 2014 Nov 19.

31.

Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicenter cross-sectional study.

Bémer P, Plouzeau C, Tande D, Léger J, Giraudeau B, Valentin AS, Jolivet-Gougeon A, Vincent P, Corvec S, Gibaud S, Juvin ME, Héry-Arnaud G, Lemarié C, Kempf M, Bret L, Quentin R, Coffre C, de Pinieux G, Bernard L, Burucoa C; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

J Clin Microbiol. 2014 Oct;52(10):3583-9. doi: 10.1128/JCM.01459-14. Epub 2014 Jul 23.

32.

Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells.

Mustapha P, Paris I, Garcia M, Tran CT, Cremniter J, Garnier M, Faure JP, Barthes T, Boneca IG, Morel F, Lecron JC, Burucoa C, Bodet C.

Infect Immun. 2014 Jul;82(7):2881-9. doi: 10.1128/IAI.01517-13. Epub 2014 Apr 28.

33.

Bacteria and vampirism in cinema.

Castel O, Bourry A, Thévenot S, Burucoa C.

Med Mal Infect. 2013 Sep;43(9):363-7. doi: 10.1016/j.medmal.2013.06.014. Epub 2013 Aug 3. Review.

PMID:
23916557
34.

[Tuberculosis and cinema].

Castel O, Boury A, Underner M, Agius G, Burucoa C, Thévenot S.

Rev Mal Respir. 2013 Apr;30(4):249-52. doi: 10.1016/j.rmr.2013.01.007. Epub 2013 Apr 9. French. No abstract available.

PMID:
23664283
35.

Proteomic biomarkers associated with Streptococcus agalactiae invasive genogroups.

Lanotte P, Perivier M, Haguenoer E, Mereghetti L, Burucoa C, Claverol S, Atanassov C.

PLoS One. 2013;8(1):e54393. doi: 10.1371/journal.pone.0054393. Epub 2013 Jan 23.

36.

Comparative evaluation of 29 commercial Helicobacter pylori serological kits.

Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F, Raymond J, Fauchère JL.

Helicobacter. 2013 Jun;18(3):169-79. doi: 10.1111/hel.12030. Epub 2013 Jan 14.

PMID:
23316886
37.

Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.

Seck A, Burucoa C, Dia D, Mbengue M, Onambele M, Raymond J, Breurec S.

Ann Clin Microbiol Antimicrob. 2013 Jan 8;12:3. doi: 10.1186/1476-0711-12-3.

38.

Proficiency of PCR in hospital settings for nonculture diagnosis of invasive meningococcal infections.

Hong E, Barraud O, Bidet P, Bingen E, Blondiaux N, Bonacorsi S, Burucoa C, Carrer A, Fortineau N, Couetdic G, Courcol R, Garnier F, Hery-Arnaud G, Lanotte P, Le Bars H, Legrand-Quillien MC, Lemée L, Mereghetti L, Millardet C, Minet J, Plouzeau-Jayle C, Pons JL, Schneider J, Taha MK.

Clin Lab. 2012;58(3-4):343-6.

PMID:
22582511
39.

Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France.

Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C.

Antimicrob Agents Chemother. 2012 Jan;56(1):550-1. doi: 10.1128/AAC.05243-11. Epub 2011 Nov 7.

40.

Evaluation of four commercial real-time PCR assays for detection of Bordetella spp. in nasopharyngeal aspirates.

Lanotte P, Plouzeau C, Burucoa C, Grélaud C, Guillot S, Guiso N, Garnier F.

J Clin Microbiol. 2011 Nov;49(11):3943-6. doi: 10.1128/JCM.00335-11. Epub 2011 Sep 14.

41.

Catabacter hongkongensis Bacteremia with fatal septic shock.

Elsendoorn A, Robert R, Culos A, Roblot F, Burucoa C.

Emerg Infect Dis. 2011 Jul;17(7):1330-1. doi: 10.3201/eid1707.101773. No abstract available.

42.

The rtxA toxin gene of Kingella kingae: a pertinent target for molecular diagnosis of osteoarticular infections.

Lehours P, Freydière AM, Richer O, Burucoa C, Boisset S, Lanotte P, Prère MF, Ferroni A, Lafuente C, Vandenesch F, Mégraud F, Ménard A.

J Clin Microbiol. 2011 Apr;49(4):1245-50. doi: 10.1128/JCM.01657-10. Epub 2011 Jan 19.

43.

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.

Ben Mansour K, Burucoa C, Zribi M, Masmoudi A, Karoui S, Kallel L, Chouaib S, Matri S, Fekih M, Zarrouk S, Labbene M, Boubaker J, Cheikh I, Hriz MB, Siala N, Ayadi A, Filali A, Mami NB, Najjar T, Maherzi A, Sfar MT, Fendri C.

Ann Clin Microbiol Antimicrob. 2010 Aug 13;9:22. doi: 10.1186/1476-0711-9-22.

44.

[Prevalence of resistance to antimicrobial agents of H. pylori].

Raymond J, Kalach N, Lamarque D, Burucoa C.

Arch Pediatr. 2010 Jun;17(6):816-7. doi: 10.1016/S0929-693X(10)70126-3. French. No abstract available.

PMID:
20654908
45.

[Diagnostic tests for Helicobacter pylori infection in children].

Burucoa C.

Arch Pediatr. 2010 Jun;17(6):814-5. doi: 10.1016/S0929-693X(10)70125-1. French. No abstract available.

PMID:
20654907
46.

From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma.

Thiberge JM, Boursaux-Eude C, Lehours P, Dillies MA, Creno S, Coppée JY, Rouy Z, Lajus A, Ma L, Burucoa C, Ruskoné-Foumestraux A, Courillon-Mallet A, De Reuse H, Boneca IG, Lamarque D, Mégraud F, Delchier JC, Médigue C, Bouchier C, Labigne A, Raymond J.

BMC Genomics. 2010 Jun 10;11:368. doi: 10.1186/1471-2164-11-368.

47.

Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients.

Ben Mansour K, Fendri C, Zribi M, Masmoudi A, Labbene M, Fillali A, Ben Mami N, Najjar T, Meherzi A, Sfar T, Burucoa C.

Ann Clin Microbiol Antimicrob. 2010 Mar 19;9:10. doi: 10.1186/1476-0711-9-10.

48.

High level of antimicrobial resistance in French Helicobacter pylori isolates.

Raymond J, Lamarque D, Kalach N, Chaussade S, Burucoa C.

Helicobacter. 2010 Feb;15(1):21-7. doi: 10.1111/j.1523-5378.2009.00737.x.

PMID:
20302586
49.

Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses.

Caro V, Guiso N, Alberti C, Liguori S, Burucoa C, Couetdic G, Doucet-Populaire F, Ferroni A, Papin-Gibaud S, Grattard F, Réglier-Poupet H, Raymond J, Soler C, Bouchet S, Charreau S, Couzon B, Leymarie I, Tavares N, Choux M, Bingen E, Bonacorsi S.

J Clin Microbiol. 2009 Oct;47(10):3197-203. doi: 10.1128/JCM.00817-09. Epub 2009 Aug 19.

50.

Proteomic Helicobacter pylori biomarkers discriminative of low-grade gastric MALT lymphoma and duodenal ulcer.

Bernarde C, Khoder G, Lehours P, Burucoa C, Fauchère JL, Delchier JC, Mégraud F, Atanassov C.

Proteomics Clin Appl. 2009 Jun;3(6):672-81. doi: 10.1002/prca.200800158.

PMID:
21136979

Supplemental Content

Loading ...
Support Center